The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 28, 2014

Filed:

Jan. 22, 2013
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Washington, DC (US);

Inventors:

Thomas Michael Kristie, Silver Spring, MD (US);

Yu Liang, Gaithersburg, MD (US);

Jodi Vogel, Bethesda, MD (US);

David J. Maloney, Point of Rocks, MD (US);

Ganesha Rai Bantukallu, Arlington, VA (US);

Anton Simeonov, Bethesda, MD (US);

Ajit Jadhav, Chantilly, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/535 (2006.01); A61K 31/497 (2006.01); C07D 239/42 (2006.01); A61K 31/496 (2006.01); A61K 31/165 (2006.01); A61K 31/7088 (2006.01); A61K 31/505 (2006.01); A61K 31/44 (2006.01); A61K 45/06 (2006.01); C07D 215/14 (2006.01); A61K 31/198 (2006.01); A61K 31/166 (2006.01); A61K 31/195 (2006.01); A61K 31/135 (2006.01); A61K 31/00 (2006.01); A61K 31/225 (2006.01); A61K 31/551 (2006.01); A61K 31/137 (2006.01); A61K 31/194 (2006.01); A61K 31/506 (2006.01); A61K 31/444 (2006.01); C07C 233/56 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/551 (2013.01); A61K 31/496 (2013.01); A61K 31/165 (2013.01); A61K 31/7088 (2013.01); A61K 31/505 (2013.01); A61K 31/44 (2013.01); A61K 45/06 (2013.01); C07D 215/14 (2013.01); A61K 31/198 (2013.01); A61K 31/166 (2013.01); A61K 31/195 (2013.01); A61K 31/135 (2013.01); A61K 31/00 (2013.01); A61K 31/225 (2013.01); A61K 31/47 (2013.01); A61K 31/137 (2013.01); A61K 31/194 (2013.01); A61K 31/506 (2013.01); A61K 31/444 (2013.01); C07C 233/56 (2013.01); A61K 31/5377 (2013.01);
Abstract

Disclosed are compounds and pharmaceutical compositions containing compounds that inhibit JMJD2 proteins, including those of the formula (I): wherein R, R, R, R, and Rare as defined herein or pharmaceutically acceptable salts thereof. Also disclosed is a method of preventing or treating a viral infection of a host, comprising administering to the host an effective amount of an inhibitor of the JMJD2 family of histone demethylases, for example, a compound of the formula (I). The viral infection may be a primary infection, reactivation of a virus after latency in a host, or may be in a mammal that has undergone, is undergoing, or will undergo immunosuppressive therapy.


Find Patent Forward Citations

Loading…